Metzinger, Laurent
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Laurent Metzinger researcher ORCID ID = 0000-0002-7636-8480
VIAF ID: 214881629 ( Personal )
Permalink: http://viaf.org/viaf/214881629
Preferred Forms
4xx's: Alternate Name Forms (1)
Works
| Title | Sources |
|---|---|
| alpha-Methylprednisolone promotes skeletal myogenesis in dystrophin-deficient and control mouse cultures |
|
| Ankylosing spondylitis and the genes involved in the disease. |
|
| Binding of the dystrophin second repeat to membrane di-oleyl phospholipids is dependent upon lipid packing. |
|
| Celiac disease : latest data on its genetics. Break through, prospects. |
|
| Crystal structure of the transfer-RNA domain of transfer-messenger RNA in complex with SmpB |
|
| Données récentes sur la dystrophine et les protéines qui lui sont associées : implications dans les maladies affectant le muscle squelettique |
|
| Dystrobrevin deficiency at the sarcolemma of patients with muscular dystrophy. |
|
| Functional and structural study of sRNAs expressed in Staphylococcus aureus. |
|
| La génétique du cancer colorectal au service de la médecine personnalisée et des traitements "sur mesure" |
|
| Glucocorticoids and lazaroids enchance the differentiation of dystrophin-deficient skeletal muscle cell cultures. |
|
| High inorganic phosphate concentration inhibits osteoclastogenesis by modulating miR-223. |
|
| The highest affinity binding site of small protein B on transfer messenger RNA is outside the tRNA domain. |
|
| Hirudo medicinalis : ancient remedy or therapy of the future ? |
|
| Hirudo medicinalis : vieux remède ou thérapeutique d'avenir? |
|
| Infarctus du myocarde : thérapie par la greffe de cellules musculaires squelettiques |
|
| Inhibition of miR-223 expression using a sponge strategy decreases restenosis in rat injured carotids |
|
| Inorganic phosphate accelerates the migration of vascular smooth muscle cells: evidence for the involvement of miR-223. |
|
| Intérêt physiopathologique des microARNs dans l'évolution de la plaque carotidienne |
|
| L'adénome hypophysaire à prolactine |
|
| Magnesium Attenuates Phosphate-Induced Deregulation of a MicroRNA Signature and Prevents Modulation of Smad1 and Osterix during the Course of Vascular Calcification. |
|
| Maladie coeliaque, dernières données sur la génétique : avancées, perspectives |
|
| The Management of Cardiovascular Risk through Epigenetic Biomarkers |
|
| Les micro-ARN : dernières avancées et implications en pathologies humaines |
|
| MicroARNs, marqueurs de la pathologie valvulaire aortique |
|
| Les microARNs : molécules innovantes dans la prise en charge de la maladie rénale chronique |
|
| MicroRNA deregulation in symptomatic carotid plaque. |
|
| microRNAs are dysregulated in the cerebral microvasculature of CKD mice. |
|
| MicroRNAs as biomarkers of aortic valve disease. |
|
| miR-126 Is Involved in Vascular Remodeling under Laminar Shear Stress. |
|
| miR-223: An inflammatory oncomiR enters the cardiovascular field |
|
| miR-92a: A Novel Potential Biomarker of Rapid Aortic Valve Calcification. |
|
| MISE AU POINT D'UNE METHODE DE CULTURE DE CELLULES MUSCULAIRES DE SOURIS : ETUDE DE L'EFFET DES GLUCOCORTICOIDES SUR CE MODELE |
|
| Modulation by prednisolone of calcium handling in skeletal muscle cells. |
|
| Mucoviscidose et nutrition |
|
| Myocardial infraction : cellular therapy by the skeletal muscular cells transplantation. |
|
| On the facultative requirement of the bacterial RNA chaperone, Hfq. |
|
| Physiopathologie et traitements classiques et émergents de la dégénérescence maculaire liée à l'âge humide |
|
| Physiopathology and classic and emergent treatments of the wet age related macular disease |
|
| Polyarthrite rhumatoi͏̈de : dernières avancées en thérapie génique |
|
| Possible involvement of microRNAs in vascular damage in experimental chronic kidney disease. |
|
| A rapid preparation of primary cultures of mouse skeletal muscle cells |
|
| Rheumatoid arthritis : recent advances in gene therapy. |
|
| Rôle de l'embryon humain en santé publique : données récentes en thérapeutique, législation et éthique |
|
| Rôle des toxines urémiques et du facteur de transcription AhR dans la modulation de l'expression des transporteurs hépatiques au cours de l'insuffisance rénale chronique |
|
| Roles and Clinical Applications of Biomarkers in Cardiovascular Disease 2017. |
|
| Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients |
|
| Serum microRNAs are altered in various stages of chronic kidney disease: a preliminary study |
|
| La spondylarthrite ankylosante et les gens impliqués dans la maladie |
|
| tmRNA and associated ligands: a puzzling relationship. |
|
| TRIM37 (nanisme Mulibrey) : implication dans le cycle cellulaire et régulation post-transcriptionnelle par le miR-223 dans les chondrocytes |
|
| TRIMming down to TRIM37: Relevance to Inflammation, Cardiovascular Disorders, and Cancer in MULIBREY Nanism |
|
| Uremic Toxins Affect Erythropoiesis during the Course of Chronic Kidney Disease: A Review |
|
| Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy |
|
